“Serum Cystatin C as an Endogenous Marker of Renal Function in Patients with Chronic Kidney Disease (CKD)”, J Curr Adv Med Res, vol. 4, no. 1, pp. 3–12, Apr. 2018, doi: 10.3329/jcamr.v4i1.36168.